外体circRNAs在瘤微环境中的免疫调节作用
Cunming Lv1,2, Jinhao Chen1,2, Yuxiang Wang3
1College of Basic Medical Sciences, China Three Gorges University, Yichang, China.
Frontiers in oncology
|March 4, 2025
概括
外体循环RNAs (circRNAs) 是癌症免疫细胞功能的关键调节者. 了解这些分子为癌症免疫治疗和诊断提供了新的途径.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 癌症发病率和死亡率不断上升,需要新的免疫治疗策略.
- 循环RNAs (circRNAs) 是一种非编码RNA类型,涉及通过外体的细胞间通信.
- 外体环RNAs影响T细胞,NK细胞和巨细胞等免疫细胞,影响瘤免疫逃避.
研究的目的:
- 审查免疫细胞中外体环RNAs的调节作用.
- 探索外体circRNAs在癌症进展和治疗中的潜力.
- 为了强调他们对推进癌症免疫疗法的承诺.
主要方法:
- 对外体circRNA及其与免疫细胞相互作用的研究的文献综述.
- 对外体环RNAs调节免疫反应的机制的分析.
- 评估外体环RNAs作为诊断生物标志物和治疗点.
主要成果:
- 外体circRNAs可以改变瘤微环境并调节免疫细胞功能.
- 瘤利用外体环RNA来逃避免疫系统的监控.
- 外体环RNA显示出作为癌症生物标志物和治疗点的潜力.
结论:
- 外体环RNA在癌症免疫力和进展中起着重要作用.
- 向外体circRNAs为增强癌症免疫治疗提供了一个有希望的策略.
- 对外体circRNA机制的进一步研究对于开发有效治疗方法至关重要.
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Tumor Immunotherapy
461
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
461


